Control Control Control Patients Patients Patients Patients Patients Patients Patients Patients Patients Patients Patients Patients
Sex% Before% Before% Before% Before% During% During% During% During% After% After% After% After%
Male Female 80.0 20.0 80.0 20.0 80.0 20.0 90.0 10.0 90.0 10.0 90.0 10.0 90.0 10.0 90.0 10.0 90.0 10.0 90.0 10.0 90.0 10.0 100 0 100 0 100 0 100 0
Age Min. – Max. Mean ± SD. 33.0 – 40.0 36.32 ± 2.43 33.0 – 40.0 36.32 ± 2.43 33.0 – 40.0 36.32 ± 2.43 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81 35.0 – 75.0 55.52 ± 4.81
Smoker% >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05 >0.05
Nil Ve- Ve+
100.0
100.0
100.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0 0.0 0.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 10.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 90.0 100.0 100.0 100.0 100.0
<0.002* <0.002* <0.002* <0.002* <0.002* <0.002* <0.002* <0.002* <0.001* <0.001* <0.001* <0.001*
Hb (g/dl)
Min. – Max.
11.3 – 16.3
11.3 – 16.3
11.3 – 16.3
11.1 – 14.8
11.1 – 14.8
11.1 – 14.8
11.1 – 14.8
8.75 – 11.0
8.75 – 11.0
8.75 – 11.0
8.75 – 11.0
8.4 – 12.4
8.4 – 12.4
8.4 – 12.4
8.4 – 12.4
Mean ± SD.
14.55 ± 2.43
14.55 ± 2.43
14.55 ± 2.43
12.72 ± 1.55
12.72 ± 1.55
12.72 ± 1.55
12.72 ± 1.55
10.15 ± 1.18
10.15 ± 1.18
10.15 ± 1.18
10.15 ± 1.18
10.3 ± 1.0
10.3 ± 1.0
10.3 ± 1.0
10.3 ± 1.0
pControl 0.732 0.732 0.732 0.732 0.824 0.824 0.824 0.824 0.643 0.643 0.643 0.643
WBCs/mm3
Min. – Max.
4750.0 – 10750.0
4750.0 – 10750.0
4750.0 – 10750.0
4.000 – 14750.0
4.000 – 14750.0
4.000 – 14750.0
4.000 – 14750.0
3420.0 – 5500.0
3420.0 – 5500.0
3420.0 – 5500.0
3420.0 – 5500.0
2020.0 – 3700.0
2020.0 – 3700.0
2020.0 – 3700.0
2020.0 – 3700.0
Mean ± SD.
7254 ± 2245.0
7254 ± 2245.0
7254 ± 2245.0
9062.0 ± 2349.0
9062.0 ± 2349.0
9062.0 ± 2349.0
9062.0 ± 2349.0
3725.0 ± 1724.0
3725.0 ± 1724.0
3725.0 ± 1724.0
3725.0 ± 1724.0
2550.0 ± 450.9
2550.0 ± 450.9
2550.0 ± 450.9
2550.0 ± 450.9
pControl <0.05* <0.05* <0.05* <0.05* <0.05* <0.05* <0.05* <0.05* <0.01* <0.01* <0.01* <0.01*
PL/mm3
Min. – Max.
Mean ± SD.
150000.0–420000.0 2770833 ±8730.9 150000.0–420000.0 2770833 ±8730.9 150000.0–420000.0 2770833 ±8730.9 120000.0 – 138000.0 128000.0 ± 1073.0 120000.0 – 138000.0 128000.0 ± 1073.0 120000.0 – 138000.0 128000.0 ± 1073.0 120000.0 – 138000.0 128000.0 ± 1073.0 33000 – 52000 35000 ± 1439 33000 – 52000 35000 ± 1439 33000 – 52000 35000 ± 1439 33000 – 52000 35000 ± 1439 35400.0 – 38000.0 26625 ± 29217 35400.0 – 38000.0 26625 ± 29217 35400.0 – 38000.0 26625 ± 29217 35400.0 – 38000.0 26625 ± 29217
pControl 0.034* 0.034* 0.034* 0.034* 0.027* 0.027* 0.027* 0.027* 0.012* 0.012* 0.012* 0.012*
Performance No. No. % No. No. No. % No. No. No. % No. No. No. %
0
0
0
0.0
1
1
1
20.0
0
0
0
0.0
5
5
5
100.0
1
0
0
0.0
2
2
2
40.0
3
3
3
60.0
0
0
0
0.0
2
0
0
0.0
2
2
2
40.0
0
0
0
0.0
0
0
0
0.0
3
0
0
0.0
0
0
0
0.0
2
2
2
40.0
0
0
0
0.0
Healthy
5
5
100.0
0
0
0
0.0
0
0
0
0.0
0
0
0
0.0
pControl FEp=0.007* FEp=0.007* FEp=0.007* FEp=0.007* FEp=0.007* FEp=0.007* FEp=0.007* FEp=0.007* FEp=0.008* FEp=0.008* FEp=0.008* FEp=0.008*
Number of indicated cycles No. % % No. % % % No. % % % No. % % %
Nil
5
100.0
100.0
5
100.0
100.0
100.0
0
0.0
0.0
0.0
0
0.0
0.0
0.0
Positive
0
0.0
0.0
0
0.0
0.0
0.0
5
100.0
100.0
100.0
5
100.0
100.0
100.0
pControl - - - - FEp=0.008* FEp=0.008* FEp=0.008* FEp=0.008* FEp=0.008* FEp=0.008* FEp=0.008* FEp=0.008*
2 Cycle
-
-
-
-
-
-
-
0
0
0.0
0.0
0
0
0.0
0.0
3 Cycle
-
-
-
-
-
-
-
3
3
100.0
100.0
1
1
20.0
20.0
4 Cycle
-
-
-
-
-
-
-
0
0
0.0
0.0
2
2
40.0
40.0
5 Cycle
-
-
-
-
-
-
-
0
0
0.0
0.0
1
1
20.0
20.0
6 Cycle
-
-
-
-
-
-
-
0
0
0.0
0.0
1
1
20.0
20.0
MCp1 0.008* 0.008* 0.008* 0.008* 0.008* 0.008* 0.008* 0.008*
Viable PBMCs count / ml after Ficol
Min. – Max. 1.27 – 1.37 1.27 – 1.37 1.27 – 1.37 0.53 – 1.50 0.53 – 1.50 0.53 – 1.50 0.53 – 1.50
0.47 – 0.65
0.47 – 0.65
0.47 – 0.65
0.47 – 0.65
0.48 – 2.50
0.48 – 2.50
0.48 – 2.50
0.48 – 2.50
Mean ± SD. 1.31 ± 0.05 1.31 ± 0.05 1.31 ± 0.05 1.01 ± 0.44 1.01 ± 0.44 1.01 ± 0.44 1.01 ± 0.44
0.60 ± 0.08
0.60 ± 0.08
0.60 ± 0.08
0.60 ± 0.08
1.17 ± 0.85
1.17 ± 0.85
1.17 ± 0.85
1.17 ± 0.85
pControl 0.310 0.310 0.310 0.310 0.008* 0.008* 0.008* 0.008* 0.690 0.690 0.690 0.690
Lymph % 31.5 31.5 31.5 69.36 69.36 69.36 69.36 54.95 54.95 54.95 54.95 49.85 49.85 49.85 49.85
Lymph (103) 2.6 2.6 2.6 2.84 2.84 2.84 2.84 1.48 1.48 1.48 1.48 0.77 0.77 0.77 0.77
Mono % 3 3 3 8.4 8.4 8.4 8.4 7.8 7.8 7.8 7.8 6.025 6.025 6.025 6.025
Mono (103) 0.255 0.255 0.255 0.344 0.344 0.344 0.344 0.210 0.210 0.210 0.210 0.093 0.093 0.093 0.093
Gran % 60 60 60 22.64 22.64 22.64 22.64 39.025 39.025 39.025 39.025 42.313 42.313 42.313 42.313
Gran (103) 5.1 5.1 5.1 0.92 0.92 0.92 0.92 1.05 1.05 1.05 1.05 0.65 0.65 0.65 0.65